Target intelligence / Profile preview

Biological Microenvironment

Molecular classification
Other
01

Overview

The biological microenvironment refers to the immediate local environment surrounding a cell, consisting of the extracellular matrix (ECM), interstitial fluid, neighboring cells such as fibroblasts and immune cells, and various signaling molecules like cytokines and growth factors (NIH, 2023; PubMed: PMC7069058). It plays a fundamental role in regulating cellular behavior, including proliferation, differentiation, and survival, by providing both biochemical and mechanical cues (Nature Reviews Molecular Cell Biology, 2014). In disease states like cancer, the tumor microenvironment (TME) is often altered to promote tumor growth, facilitate metastasis, and provide a niche for immune evasion (StatPearls, 2023). Therapeutic interventions often aim to modulate specific components of the microenvironment, such as inhibiting angiogenesis or reprogramming immune cell activity, rather than targeting the environment as a single entity (Journal of Hematology & Oncology, 2021). Consequently, while the microenvironment is a critical focus of drug development, it is considered a complex system rather than a discrete molecular target (PubChem, 2024). Understanding the dynamic interactions within this environment is essential for developing effective multi-modal treatment strategies that can overcome drug resistance and improve patient outcomes.

Other names
Cellular microenvironmentTissue microenvironmentExtracellular environmentNiche
02

Mechanism of action

Therapeutic strategies involve the modulation of the extracellular matrix, inhibition of pro-angiogenic signaling, and the reprogramming of immune cell populations within the local tissue environment to restore homeostasis or enhance anti-tumor activity.

03

Biological functions

Cell signalingStructural supportMetabolic regulationImmune response modulationHomeostasis
04

Disease associations

CancerInflammationFibrosisInfectionCardiovascular disease
05

Safety considerations

Systemic toxicity from modulating ubiquitous environmental factorsDisruption of normal tissue homeostasisImmune-related adverse events (irAEs)Impaired wound healing and tissue repair
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

Hypoxia-inducible factor 1-alpha (HIF-1α)Extracellular pHLactateMatrix metalloproteinases (MMPs)Vascular endothelial growth factor (VEGF)

Beyond the preview

Go deeper on Biological Microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological Microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call